Sirtris Pharmaceuticals, Inc.

Contact

Site Map

Sirtris is focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, such as Type 2 Diabetes. Our research focus is on modulating the sirtuins, a recently discovered class of enzymes involved in the aging process.

Sirtris, a GSK company www.gsk.com

+ 10.27.09	Sirtris presented at Boston Biotech R&D Conference
+ 09.29.09	Sirtris appoints two new members to its Scientific Advisory Board
+ 09.23.09	Sirtris presented at the Aging & Healthy Lifespan Conference
+ 09.22.09	Sirtris presented at the Metabolic Diseases Drug Discovery & Development Conference
+ 09.04.09	Sirtris publishes the first reported human SIRT3 crystal structure in The Journal of Biological Chemistry
+ 07.07.09	Sirtris makes two key appointments
+ 06.22.09	Sirtris honored with American Business Awards for Best Overall Company of the Year and Executive of the Year

Find information regarding our clinical trials and areas of research. Learn more

+ 02.01.10

Sirtris Presents at the Keystone Symposia: New Insights into Healthspan and Diseases of Aging: From Molecular to Functional Senescence